Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999–2004 National Health and Nutrition Examination Survey

Clinical Nutrition

Volumn 35, Issue 6, 2016, Pages 1472-1483

  Batsis, John A ^a,b,c,d,e   Mackenzie, Todd A ^b   Jones, Jonathan D ^a,b   Lopez Jimenez, Francisco ^f   Bartels, Stephen J ^b,c,d  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^c DARTMOUTH COLLEGE   (United States)

^d Health Promotion Research Center at Dartmouth   (United States)

^e Dartmouth Weight and Wellness Center   (United States)

^f MAYO CLINIC   (United States)

Author keywords

Inflammation; Insulin resistance; Obesity; Sarcopenia

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; BIOLOGICAL MARKER; CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRIC PARAMETERS; APPENDICULAR LEAN MASS; ARTICLE; BODY COMPOSITION; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; GLUCOSE HOMEOSTASIS; HEALTH CARE SURVEY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; SARCOPENIA; SARCOPENIC OBESITY; SEX DIFFERENCE; SMOKING HABIT; VERY ELDERLY; WAIST CIRCUMFERENCE; BLOOD; COMPLICATION; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; NUTRITION; OBESITY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PREVALENCE; QUESTIONNAIRE; SOCIOECONOMICS;

ABSORPTIOMETRY, PHOTON; ADIPOSITY; AGED; AGED, 80 AND OVER; BIOMARKERS; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; INSULIN; MALE; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; PREVALENCE; SARCOPENIA; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84963706134     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2016.03.028     Document Type: Article

References (30)

1. [1] Ogden, C.L., Carroll, M.D., Kit, B.K., Flegal, K.M., Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311 (2014), 806–814, 10.1001/jama.2014.732.
2. [2] Studenski, S.A., Peters, K.W., Alley, D.E., Cawthon, P.M., McLean, R.R., Harris, T.B., et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69 (2014), 547–558, 10.1093/gerona/glu010.
3. [3] Baumgartner, R.N., Wayne, S.J., Waters, D.L., Janssen, I., Gallagher, D., Morley, J.E., Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 12 (2004), 1995–2004, 10.1038/oby.2004.250.
4. [4] Levine, M., Crimmins, E., The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning. Obesity 20:10 (2012), 2101–2106, 10.1038/oby.2012.20 (Silver Spring).
5. [5] Schrager, M.A., Metter, E.J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 102 (2007), 919–925, 10.1152/japplphysiol.00627.2006.
6. [6] Levy, J.C., Matthews, D.R., Hermans, M.P., Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21 (1998), 2191–2192.
7. [7] Stenholm, S., Harris, T.B., Rantanen, T., Visser, M., Kritchevsky, S.B., Ferrucci, L., Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metabolic Care 11 (2008), 693–700, 10.1097/MCO.0b013e328312c37d.
8. [8] Stenholm, S., Rantanen, T., Heliovaara, M., Koskinen, S., The mediating role of C-reactive protein and handgrip strength between obesity and walking limitation. J Am Geriatr Soc 56 (2008), 462–469, 10.1111/j.1532-5415.2007.01567.x.
9. [9] Batsis, J.A., Barre, L.K., Mackenzie, T.A., Pratt, S.I., Lopez-Jimenez, F., Bartels, S.J., Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy x-ray absorptiometry data from the national health and nutrition examination survey 1999–2004. J Am Geriatr Soc 61 (2013), 974–980, 10.1111/jgs.12260.
10. [10] Batsis, J.A., Mackenzie, T.A., Barre, L.K., Lopez-Jimenez, F., Bartels, S.J., Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National health and nutrition examination survey III. Eur J Clin Nutr 68 (2014), 1001–1007, 10.1038/ejcn.2014.117.
11. [11] Batsis, J.A., Nieto-Martinez, R.E., Lopez-Jimenez, F., Metabolic syndrome: from global epidemiology to individualized medicine. Clin Pharmacol Ther 82 (2007), 509–524, 10.1038/sj.clpt.6100355.
12. [12] Kim, T.N., Yang, S.J., Yoo, H.J., Lim, K.I., Kang, H.J., Song, W., et al. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes 33 (2009), 885–892, 10.1038/ijo.2009.130.
13. [13] Lee, C.G., Boyko, E.J., Strotmeyer, E.S., Lewis, C.E., Cawthon, P.M., Hoffman, A.R., et al. Association between insulin resistance and lean mass loss and fat mass gain in older men without diabetes mellitus. J Am Geriatr Soc 59 (2011), 1217–1224, 10.1111/j.1532-5415.2011.03472.x.
14. [14] Lim, S., Kim, J.H., Yoon, J.W., Kang, S.M., Choi, S.H., Park, Y.J., et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean longitudinal study on health and aging (KLoSHA). Diabetes Care 33 (2010), 1652–1654, 10.2337/dc10-0107.
15. [15] Srikanthan, P., Karlamangla, A.S., Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National health and nutrition examination survey. J Clin Endocrinol Metab 96 (2011), 2898–2903, 10.1210/jc.2011-0435.
16. [16] Schaap, L.A., Pluijm, S.M., Deeg, D.J., Harris, T.B., Kritchevsky, S.B., Newman, A.B., et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 64 (2009), 1183–1189, 10.1093/gerona/glp097.
17. [17] Fried, S.K., Bunkin, D.A., Greenberg, A.S., Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83 (1998), 847–850, 10.1210/jcem.83.3.4660.
18. [18] Cesari, M., Pahor, M., Lauretani, F., Zamboni, V., Bandinelli, S., Bernabei, R., et al. Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci 64 (2009), 377–384, 10.1093/gerona/gln031.
19. [19] Park, S.W., Goodpaster, B.H., Strotmeyer, E.S., de Rekeneire, N., Harris, T.B., Schwartz, A.V., et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes 55 (2006), 1813–1818, 10.2337/db05-1183.
20. [20] Park, S.W., Goodpaster, B.H., Strotmeyer, E.S., Kuller, L.H., Broudeau, R., Kammerer, C., et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care 30 (2007), 1507–1512, 10.2337/dc06-2537.
21. [21] Peppa, M., Koliaki, C., Nikolopoulos, P., Raptis, S.A., Skeletal muscle insulin resistance in endocrine disease. J Biomed Biotechnol, 2010, 2010, 527850, 10.1155/2010/527850.
22. [22] Hotamisligil, G.S., The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 245 (1999), 621–625.
23. [23] Roubenoff, R., Freeman, L.M., Smith, D.E., Abad, L.W., Dinarello, C.A., Kehayias, J.J., Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum 40 (1997), 534–539.
24. [24] Batsis, J.A., Sahakyan, K.R., Singh, P., Bartels, S.J., Somers, V.K., Lopez-Jimenez, F., Leptin, adiposity, and mortality: results from the national health and nutrition examination survey III, 1988 to 1994. Mayo Clin Proc 90 (2015), 481–491, 10.1016/j.mayocp.2015.01.023.
25. [25] Guillet, C., Zangarelli, A., Gachon, P., Morio, B., Giraudet, C., Rousset, P., et al. Whole body protein breakdown is less inhibited by insulin, but still responsive to amino acid, in nondiabetic elderly subjects. J Clin Endocrinol Metab 89 (2004), 6017–6024, 10.1210/jc.2003-031323.
26. [26] Rasmussen, B.B., Fujita, S., Wolfe, R.R., Mittendorfer, B., Roy, M., Rowe, V.L., et al. Insulin resistance of muscle protein metabolism in aging. FASEB J 20 (2006), 768–769, 10.1096/fj.05-4607fje.
27. [27] Batsis, J.A., Mackenzie, T.A., Bartels, S.J., Sahakyan, K.R., Somers, V.K., Lopez-Jimenez, F., Diagnostic accuracy of body mass index to identify obesity in older adults: NHANES 1999–2004. Int J Obes (Lond), 2015, 10.1038/ijo.2015.243.
28. [28] Batsis, J.A., Mackenzie, T.A., Lopez-Jimenez, F., Bartels, S.J., Sarcopenia, sarcopenic obesity, and functional impairments in older adults: national Health and Nutrition Examination Surveys 1999–2004. Nutr Res 35 (2015), 1031–1039, 10.1016/j.nutres.2015.09.003.
29. [29] Landi, F., Liperoti, R., Fusco, D., Mastropaolo, S., Quattrociocchi, D., Proia, A., et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 13 (2012), 121–126, 10.1016/j.jamda.2011.07.004.
30. [30] Zizza, C.A., Herring, A., Stevens, J., Popkin, B.M., Obesity affects nursing-care facility admission among whites but not blacks. Obes Res 10 (2002), 816–823, 10.1038/oby.2002.110.